We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-3.06%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$77.7B
AUM Growth
-$3.9B
(-4.8%)
Cap. Flow
+$505M
Cap. Flow
% of AUM
0.65%
Top 10 Holdings %
Top 10 Hldgs %
24.09%
Holding
3,066
New
55
Increased
1,481
Reduced
1,461
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$83.5M |
| 2 |
S&P Global
SPGI
|
+$73.5M |
| 3 |
Tesla
TSLA
|
+$55.8M |
| 4 |
Microsoft
MSFT
|
+$45.9M |
| 5 |
Amazon
AMZN
|
+$27.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$88.8M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$74.7M |
| 3 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$31.7M |
| 4 |
Abbott
ABT
|
+$25.5M |
| 5 |
Exelon
EXC
|
+$23.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.74% |
| 2 | Financials | 13.53% |
| 3 | Healthcare | 13.01% |
| 4 | Consumer Discretionary | 11.66% |
| 5 | Industrials | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MAGN
1926
Magnera Corp
MAGN
$458M
| $1.59M | ﹤0.01% |
9,854
+21
| +0.2% | +$4.16K |
|
1927
Laureate Education
LAUR
$5.19B
| $1.58M | ﹤0.01% |
133,704
-30,404
| -19% | -$369K |
|
|
TVRD
1928
Tvardi Therapeutics
TVRD
$21.9M
| $1.58M | ﹤0.01% |
3,610
+2
| +0.1% | +$821 |
|
|
RVNC
1929
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.58M | ﹤0.01% |
80,902
-759
| -0.9% | -$11.5K |
|
1930
OceanFirst Financial
OCFC
$1.87B
| $1.56M | ﹤0.01% |
77,775
-7,339
| -9% | -$164K |
|
1931
Comstock Resources
CRK
$4.2B
| $1.56M | ﹤0.01% |
119,730
-11,833
| -9% | -$105K |
|
|
JAMF
1932
DELISTED
Jamf
JAMF
| $1.55M | ﹤0.01% |
44,581
-6,773
| -13% | -$230K |
|
1933
Columbus McKinnon
CMCO
$556M
| $1.55M | ﹤0.01% |
36,487
-2,988
| -8% | -$135K |
|
1934
Prothena Corp
PRTA
$447M
| $1.55M | ﹤0.01% |
42,313
-2,110
| -5% | -$76.1K |
|
|
VMEO
1935
DELISTED
Vimeo
VMEO
| $1.55M | ﹤0.01% |
130,159
-12,511
| -9% | -$167K |
|
1936
DXP Enterprises
DXPE
$3.04B
| $1.53M | ﹤0.01% |
56,547
-465
| -0.8% | -$13.2K |
|
1937
Kymera Therapeutics
KYMR
$8.87B
| $1.53M | ﹤0.01% |
36,208
+2,481
| +7% | +$105K |
|
1938
JFrog
FROG
$10.7B
| $1.53M | ﹤0.01% |
56,791
+1,331
| +2% | +$33.7K |
|
|
FLNA
1939
Filana Therapeutics
FLNA
$48.3M
| $1.53M | ﹤0.01% |
41,144
+2,230
| +6% | +$94.5K |
|
1940
Resources Connection
RGP
$147M
| $1.52M | ﹤0.01% |
88,796
-1,714
| -2% | -$29.5K |
|
|
HIBB
1941
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $1.52M | ﹤0.01% |
34,287
-2,969
| -8% | -$161K |
|
|
PFC
1942
DELISTED
Premier Financial Corp. Common Stock
PFC
| $1.52M | ﹤0.01% |
50,068
-6,321
| -11% | -$194K |
|
1943
DMC Global
BOOM
$155M
| $1.52M | ﹤0.01% |
49,770
+2,768
| +6% | +$100K |
|
1944
State Street SPDR S&P 500 ETF Trust
SPY
$810B
| $1.52M | ﹤0.01% |
3,361
| – | – |
|
|
WW
1945
DELISTED
WW International
WW
| $1.52M | ﹤0.01% |
148,265
+4,435
| +3% | +$52K |
|
1946
Center Bancorp
CNOB
$1.77B
| $1.52M | ﹤0.01% |
47,348
-4,585
| -9% | -$153K |
|
1947
Forrester Research
FORR
$225M
| $1.52M | ﹤0.01% |
26,868
+1,227
| +5% | +$66.2K |
|
|
HAYN
1948
DELISTED
Haynes International, Inc.
HAYN
| $1.52M | ﹤0.01% |
35,581
-120
| -0.3% | -$4.73K |
|
|
CWEN.A
1949
DELISTED
Clearway Energy Class A
CWEN.A
| $1.51M | ﹤0.01% |
45,483
-3,220
| -7% | -$101K |
|
1950
SkinHealth Systems
SKIN
$82.8M
| $1.51M | ﹤0.01% |
89,677
+5,701
| +7% | +$94.1K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2022 Portfolio in Review
As of Q1 2022, RhumbLine Advisers held 3,066 positions worth $77.7B, down 4.8% from $81.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Trading was light in Q1 2022: portfolio turnover was 3.5%. RhumbLine Advisers opened 55 new positions and exited 51, leaving the 3,066-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2022 buy was Constellation Energy: 528,261 shares worth $29.7M.
- RhumbLine Advisers added most to Advanced Micro Devices in Q1 2022, an estimated $83.5M increase.
- RhumbLine Advisers's biggest Q1 2022 reduction was Abbott, cutting an estimated $25.5M.
- RhumbLine Advisers fully exited Xilinx Inc in Q1 2022, selling an estimated $88.8M.
- RhumbLine Advisers's ten largest holdings make up 24% of its $77.7B portfolio in Q1 2022.
- RhumbLine Advisers opened 55 new positions and closed 51 in Q1 2022.
- RhumbLine Advisers's portfolio value fell 4.8% quarter-over-quarter to $77.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2022, filed 12 May 2022.